Clinical Research Directory
Browse clinical research sites, groups, and studies.
Physical Activity Level at Home in CMT1A Patients: Wearable Sensor Assessment
Sponsor: University Hospital, Limoges
Summary
Charcot-Marie-Tooth disease type 1A (CMT1A) is the most common hereditary peripheral neuropathy, affecting approximately 26,000 patients in France. It presents as chronic and progressive sensorimotor deficits predominantly affecting the distal lower limbs, with onset typically in childhood. There is currently no specific pharmacological treatment; management remains symptomatic. This research will: In the long run, validated wearable sensors could improve patient follow-up, personalize rehabilitation, and support the design of clinical trials for CMT1A - including trials of the novel "Nano-Cur" treatment currently under development.
Official title: Study of the Relationship Between Clinical and Functional Characteristics of Patients With CMT1A Disease and Their Level of Physical Activity at Home Measured Using Portable Electronic Sensors
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
60
Start Date
2026-06-01
Completion Date
2027-06-30
Last Updated
2026-05-22
Healthy Volunteers
No
Conditions
Locations (1)
Chu de Limoges
Limoges, France